Study of AeviceMD Device for Managing Asthma in Children and Adults Using Remote Monitoring to Reduce Asthma Attacks and Improve Quality of Life

What this Trial Is About

Researchers are evaluating the AeviceMD Monitoring System for asthma to see if it can reduce acute exacerbations and improve outcomes such as quality of life, self-efficacy, and cost-effectiveness. This study involves both pediatric patients aged 7 and older and adults, with a follow-up period of three months. It also assesses the usability of the device from both patients and clinicians perspectives to understand its practical application in asthma management. Participants are randomly assigned to two groups one receives standard care which includes nurse telephone follow-ups and doctor visits along with an asthma action plan, while the other group receives the AeviceMD device in addition to standard care. The device is used mainly at night for at least five hours but can be used anytime. AeviceMD records breathing rates and lung sounds, providing patients with objective lung data to help manage asthma symptoms and share with their clinicians during follow-ups. Throughout the 12-week study, participants will be monitored with various assessments including rescue therapy use, oral Prednisolone dose, emergency visits, hospitalizations, and quality of life questionnaires. The study also tracks self-efficacy, device usage, and clinician feedback. Participants will return the device after the study, and researchers will evaluate the impact on asthma control and healthcare utilization to understand the devices role in improving asthma management.

Remote Patient Monitoring Solution for Chronic Respiratory Disease Management